|
|
Article: Prospective study: no rise in fetal anomalies with azithromycin use; May be good first-line choice in pregnancy.(News)
- Article from:
- OB GYN News
- Article date:
- May 15, 2004
- Author:
CopyrightCOPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MIAMI BEACH -- Gestational exposure to azithromycin was not associated with an increased risk above baseline for major fetal anomalies in a prospective, controlled trial of 369 pregnant women.
The antibiotic had a safety profile comparable to the profiles of other nonteratogenic agents. The results of the trial suggest that the drug may be a good first-line choice for some infections that occur in pregnancy, particularly among traditionally noncompliant populations, because of its demonstrated efficacy and simple one-dose regimen, Moumita Sarkar reported in a poster presentation given at the annual meeting of the American Society for Clinical Pharmacology and ...